These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 33723038

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Ten Years with New Delhi Metallo-β-lactamase-1 (NDM-1): From Structural Insights to Inhibitor Design.
    Linciano P, Cendron L, Gianquinto E, Spyrakis F, Tondi D.
    ACS Infect Dis; 2019 Jan 11; 5(1):9-34. PubMed ID: 30421910
    [Abstract] [Full Text] [Related]

  • 6. A close look onto structural models and primary ligands of metallo-β-lactamases.
    Raczynska JE, Shabalin IG, Minor W, Wlodawer A, Jaskolski M.
    Drug Resist Updat; 2018 Sep 11; 40():1-12. PubMed ID: 30466711
    [Abstract] [Full Text] [Related]

  • 7. Potential inhibitors designed against NDM-1 type metallo-β-lactamases: an attempt to enhance efficacies of antibiotics against multi-drug-resistant bacteria.
    Khan AU, Ali A, Danishuddin, Srivastava G, Sharma A.
    Sci Rep; 2017 Aug 23; 7(1):9207. PubMed ID: 28835636
    [Abstract] [Full Text] [Related]

  • 8. Fragment-based discovery of inhibitor scaffolds targeting the metallo-β-lactamases NDM-1 and VIM-2.
    Christopeit T, Leiros HK.
    Bioorg Med Chem Lett; 2016 Apr 15; 26(8):1973-7. PubMed ID: 26976213
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Efforts towards the inhibitor design for New Delhi metallo-beta-lactamase (NDM-1).
    Nagulapalli Venkata KC, Ellebrecht M, Tripathi SK.
    Eur J Med Chem; 2021 Dec 05; 225():113747. PubMed ID: 34391033
    [Abstract] [Full Text] [Related]

  • 11. Stereochemically altered cephalosporins as potent inhibitors of New Delhi metallo-β-lactamases.
    Hu L, Yang H, Yu T, Chen F, Liu R, Xue S, Zhang S, Mao W, Ji C, Wang H, Xie H.
    Eur J Med Chem; 2022 Mar 15; 232():114174. PubMed ID: 35152091
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Identification of the Inhibitory Compounds for Metallo-β-lactamases and Structural Analysis of the Binding Modes.
    Kamo T, Kuroda K, Kondo S, Hayashi U, Fudo S, Yoneda T, Takaya A, Nukaga M, Hoshino T.
    Chem Pharm Bull (Tokyo); 2021 Mar 15; 69(12):1179-1183. PubMed ID: 34853284
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Probing the Interaction of Aspergillomarasmine A with Metallo-β-lactamases NDM-1, VIM-2, and IMP-7.
    Bergstrom A, Katko A, Adkins Z, Hill J, Cheng Z, Burnett M, Yang H, Aitha M, Mehaffey MR, Brodbelt JS, Tehrani KHME, Martin NI, Bonomo RA, Page RC, Tierney DL, Fast W, Wright GD, Crowder MW.
    ACS Infect Dis; 2018 Feb 09; 4(2):135-145. PubMed ID: 29091730
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.